Large-scale testing (Phase 3)UnknownNCT06186986What this trial is testingCD30 Imaging in Diffuse Large B-cell LymphomaWho this might be right forDiffuse Large B-cell-lymphoma University Medical Center Groningen 20
Testing effectiveness (Phase 2)Looking for participantsNCT06828991What this trial is testingEvaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHPWho this might be right forDiffuse Large B-Cell Lymphoma (DLBCL) Danielle Wallace 40
Large-scale testing (Phase 3)Study completedNCT00003341What this trial is testingEpoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By ChemotherapyWho this might be right forAnemiaLeukemiaLymphoma+1 more Memorial Sloan Kettering Cancer Center 275
Testing effectiveness (Phase 2)UnknownNCT02733380What this trial is testingChidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell LymphomaWho this might be right forDiffuse Large B-cell Lymphoma Henan Cancer Hospital 20
Not applicableStudy completedNCT06782854What this trial is testingUnderstanding the Role of Large Extracellular Vesicles in Lymphomas and Lymphoproliferative Disorders: the "Off the Beaten Track" Liquid BiopsyWho this might be right forDiffuse Large B-Cell LymphomaFollicular LymphomaMarginal Zone Lymphoma(MZL)+5 more IRCCS Azienda Ospedaliero-Universitaria di Bologna 102
Testing effectiveness (Phase 2)Study completedNCT00823524What this trial is testingDonor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more Asan Medical Center 47
Testing effectiveness (Phase 2)Ended earlyNCT05179603What this trial is testingSAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205]Who this might be right forClassic Hodgkin LymphomaDiffuse Large B-cell Lymphoma Sanofi 14
Not applicableWithdrawnNCT04503538What this trial is testingTelemedicine for Early Detection of Cytokine Release Syndrome and NeurotoxicityWho this might be right forLarge B-cell LymphomaDiffuse Large B Cell LymphomaPrimary Mediastinal Large B Cell Lymphoma+2 more Wake Forest University Health Sciences
Large-scale testing (Phase 3)Study completedNCT00003687What this trial is testingTreatment for Chronic Pain in Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+6 more NCIC Clinical Trials Group 87
Early research (Phase 1)UnknownNCT00023816What this trial is testingCarbendazim in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT00310128What this trial is testingCombination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's LymphomaWho this might be right forAIDS-related LymphomaAdult Non-Hodgkin's LymphomaAnaplastic Large Cell Lymphoma AIDS Malignancy Consortium
Testing effectiveness (Phase 2)Active Not RecruitingNCT04572763What this trial is testingCopanlisib Plus Venetoclax in R/R DLBCLWho this might be right forDiffuse Large B Cell LymphomaRelapsed Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma Dana-Farber Cancer Institute 48
Very early researchLooking for participantsNCT04139304What this trial is testingDaratumumab and Dose-Adjusted EPOCH in Plasmablastic LymphomaWho this might be right forPlasmablastic LymphomaAnn Arbor Stage I Diffuse Large B-Cell LymphomaAnn Arbor Stage II Diffuse Large B-Cell Lymphoma+2 more AIDS Malignancy Consortium 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03064867What this trial is testingVenetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell LymphomaWho this might be right forDiffuse Large B-cell-lymphoma Molly Gallogly 65
Large-scale testing (Phase 3)Study completedNCT01459887What this trial is testingStudy of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's LymphomaWho this might be right forDiffuse Large B Cell Lymphoma Shanghai CP Guojian Pharmaceutical Co., Ltd. 278
Testing effectiveness (Phase 2)Looking for participantsNCT06158399What this trial is testingAZA Combined With RCHOP in P53-mutated DLBCL.Who this might be right forDLBCL - Diffuse Large B Cell LymphomaTP53 The First Affiliated Hospital of Xiamen University 52
Testing effectiveness (Phase 2)Study completedNCT00134004What this trial is testingFludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 210
Large-scale testing (Phase 3)Study completedNCT00661999What this trial is testingDarbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With CancerWho this might be right forAnemiaLeukemiaLymphoma+4 more Mayo Clinic 502
Not applicableEnded earlyNCT01408043What this trial is testingEtoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin LymphomaWho this might be right forAdult Acute Lymphoblastic Leukemia in RemissionAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell Lymphoma+31 more Case Comprehensive Cancer Center 25
Testing effectiveness (Phase 2)Ended earlyNCT00005852What this trial is testingBone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow TransplantWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more H. Lee Moffitt Cancer Center and Research Institute